thymidine has been researched along with Hepatopulmonary Syndrome in 1 studies
Hepatopulmonary Syndrome: A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zeng, J | 1 |
| Yi, B | 1 |
| Wang, Z | 1 |
| Ning, J | 1 |
| Wang, X | 1 |
| Lu, K | 1 |
1 other study available for thymidine and Hepatopulmonary Syndrome
| Article | Year |
|---|---|
Effect of annexin A2 on hepatopulmonary syndrome rat serum-induced proliferation of pulmonary arterial smooth muscle cells.
Topics: Animals; Annexin A2; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Down-Regulation; H | 2013 |